Safety of Concurrent Radiation Therapy With Brentuximab Vedotin in the Treatment of Lymphoma
Advances in Radiation Oncology(2023)
摘要
Our analysis demonstrates that the combination of BV and RT is well tolerated, though care should be taken during RT planning to reduce the risk of HT. This combination can be considered for patients in need of both local and systemic disease control.
更多查看译文
关键词
brentuximab vedotin,lymphoma,concurrent radiation therapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要